Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. Biogen
  3. News

Biogen

  • Overview
  • Financial
  • In Reports
  • Products
  • News

In News

Bulls Announce New Partnership with Biogen Foundation - MLB.com

MLB.com - Jul 08, 2025

STADA brings in Biogen exec to head Specialty business - The Pharma Letter

The Pharma Letter - Jul 08, 2025

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy - Biogen

Biogen - Jun 30, 2025

Blackhawk Capital Partners LLC. Makes New $382,000 Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

MarketBeat - Jul 08, 2025

Who’s Hired? Stada Picks Biogen’s Biosimilars Chief Henshaw To Lead Specialty Segment - insights.citeline.com

insights.citeline.com - Jul 08, 2025

Biogen sees negative Q2 impact from IPR&D, milestone expenses - Seeking Alpha

Seeking Alpha - Jul 07, 2025

Sage’s Search for Lifeline Ran Into Defiant Biogen CEO - BioSpace

BioSpace - Jul 03, 2025

Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit - MSN

MSN - Jul 08, 2025

Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit - Stocktwits

Stocktwits - Jul 07, 2025

New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA - Biogen

Biogen - Jun 27, 2025

Allspring Global Investments Holdings LLC Acquires 4,019 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

MarketBeat - Jul 08, 2025

Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia - Biogen

Biogen - Jun 18, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All